SF

Satessh Fuulari

Active Director Director DIN 09692719
DIN 09692719 First appointment Aug 2022 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Satessh Fuulari

Data last updated:

Satessh Fuulari is a Director at Chairo Pharmaceuticals Private Limited (since 2022). The company operates in Food And Beverages. Chairo Pharmaceuticals Private Limited reported revenue of ₹11.7 Lakh (FY 2025).

DIN 09692719
Primary Designation Director
Industry Food And Beverages
First Appointment 01 Aug 2022
Oldest Company Age 4 yrs
Largest company Chairo Pharmaceuticals Private Limited · ₹11.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20222022₹11.7 Lakh (FY 2025)Active

Board colleagues of Satessh Fuulari

Directorship timeline

Open interactive timeline →
Chairo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Satessh Fuulari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satessh Fuulari

Satessh Fuulari currently holds 1 directorship: Chairo Pharmaceuticals Private Limited (Director, since 01 Aug 2022, revenue ₹11.7 Lakh (FY 2025)).

Satessh Fuulari was first appointed on 01 Aug 2022 as Director at Chairo Pharmaceuticals Private Limited.

The current boards of Satessh Fuulari's companies include Harrshada Satessh Fuulari (Chairo Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available